Correction: Covidien shares should be bought on pullbacks, says RBC Capital After Covidien reported better than expected Q1 results and the company reiterated its previous FY14 revenue guidance but slightly raised its tax rate guidance, RBC Capital has increased confidence in the company's operating margin outlook. The firm thinks the company looks well-positioned to return to double-digit EPS growth in F2H14. However, it keeps a Sector Perform rating on the shares. A previous article incorrectly stated that the firm had an Outperform rating on the stock.
News For COV From The Last 14 Days
Check below for free stories on COV the last two weeks.